Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Nov 2;17(11):4115-4116.
doi: 10.1080/21645515.2021.1959149. Epub 2021 Sep 2.

Reply letter to "safety of SARS-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance"

Rebeca Saborido-Fiaño  1 , Nazareth Martinón-Torres  1 , Vanesa Crujeiras-Martinez  1 , Maria Luz Couce  2 , Rosaura Leis  1
Affiliations
Comment

Reply letter to "safety of SARS-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance"

Rebeca Saborido-Fiaño et al. Hum Vaccin Immunother. .

Abstract

In the letter, Urro et al. performed a search on the sucrose, fructose and sorbitol content in the approved Sars-Cov-2 vaccines and they concluded that these vaccines can be safely administered in adults affected by Hereditary fructose intolerance.The Pfizer-BioNTech COVID-19 Vaccine is currently approved for use in adolescents ≥ 12 years and the Moderna COVID-19 vaccine is close to approval for use in children over 12 years of age. Furthermore, both vaccines have initiated clinical trials that will include infant as young as 6 months. Therefore, we considerate important to analyze the safely administration of this two vaccines in children with Hereditary fructose intolerance.

Keywords: SARS-Cov 2; vaccine; Hereditary fructose intolerance; children; sucrose.

PubMed Disclaimer

Comment on

References

    1. Urru SAM, Maines E, Campomori A, Soffiati M.. Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance. Hum Vaccin Immunother. 2021:1-3. doi:10.1080/21645515.2021.1943992. - DOI - PMC - PubMed
    1. European Medicines Agency . First COVID-19 vaccine approved for children aged 12 to 15 in EU. News May 28, 2021. https://www.ema.europa.eu/en/news/first-covid-19-vaccine-approved-childr....
    1. Food and Drug Administration . Coronavirus (COVID-19) Update: FDA Authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic. May, 2021. https//www.fda.gov/news-events/press-announcements/coronavirus-covid-19-...
    1. European Medicines Agency . EMA evaluating the use of COVID-19 Vaccine Moderna in young people aged 12 to 17. News, June 06, 2021. https://www.ema.europa.eu/en/news/ema-evaluating-use-covid-19-vaccine-mo...
    1. Garrido C, Curtis AD, Dennis M, Pathak SH, Gao H, Montefiori D, Tomai M, Fox CB, Kozlowski PA, Scobey T, et al. Sars Cov 2 vaccines elicit durable immune responses in infant Rhesus macaques. Sci Immunol. 2021. 15;6(60):eabj3684. doi:10.1126/sciimmunol.abj3684 - DOI - PMC - PubMed